CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 13 of 23

RMD Open

Briefs 481–520 of 899 CurrentRheuma has covered from this journal, newest publication first

Latest from RMD Open

All coverage, newest first

  1. RMD Open

    Exploratory analysis of the potential disconnect between objective inflammatory response and clinical response following certolizumab pegol treatment in patients with active axial spondyloarthritis

    Secondary analysisSpondyloarthritis & PsA

  2. RMD Open

    Fcγ-receptor-IIIA bioactivity of circulating and synovial immune complexes in rheumatoid arthritis

    Mechanistic studyRA

  3. RMD Open

    Long-term safety and efficacy of anti-TNF multivalent VHH antibodies ozoralizumab in patients with rheumatoid arthritis

    Research articleRA

  4. RMD Open

    miRNAs as potential biomarkers for subclinical atherosclerosis in Sjögren’s disease

    Case-control studySjögren's & overlap

  5. RMD Open

    Arrhythmia in patients with systemic sclerosis: incidence, risk factors and impact on mortality in a Swedish register-based study

    Cohort studySystemic sclerosis

  6. RMD Open

    Significant decrease of osteoporosis and osteoporotic fractures in rheumatoid arthritis within a period of 24 years: experiences of a single centre

    Cohort studyOsteoporosis

  7. RMD Open

    Next-generation rheumatoid factor assay provides improved predictive power for the development of arthritis in patients at risk

    Cohort studyRA

  8. RMD Open

    ‘Gout was like the boss’. A qualitative study exploring the impact of gout on employment

    Research articleGout & crystals

  9. RMD Open

    Sensitivity of classification criteria from time of diagnosis in an incident systemic lupus erythematosus cohort: a population-based study from Norway

    Cohort studyLupus & APS

  10. RMD Open

    More severe parotid gland histopathology in paediatric-onset than in adult-onset Sjögren’s disease

    Cross-sectional studyPediatric

  11. RMD Open

    Diagnostic accuracy of serum biomarkers to identify giant cell arteritis in patients with polymyalgia rheumatica

    Diagnostic or prognostic studyVasculitis & PMR

  12. RMD Open

    Effectiveness of methotrexate and bridging glucocorticoids with or without early introduction of a 6-month course of etanercept in early RA: results of the 2-year, pragmatic, randomised CareRA2020 trial

    Randomized controlled trialRA

  13. RMD Open

    Impact of initiation of targeted therapy on the use of psoriatic arthritis-related treatments and healthcare consumption: a cohort study of 9793 patients from the French health insurance database (SNDS)

    Cohort studySpondyloarthritis & PsA

  14. RMD Open

    Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study

    Randomized controlled trialRA

  15. RMD Open

    Sensitivity to change of structural outcomes in axial spondyloarthritis after 10 years of follow up. Data from the DESIR cohort

    Cohort studySpondyloarthritis & PsA

  16. RMD Open

    Does therapy with immunosuppressive drugs improve gastrointestinal symptoms in patients with systemic sclerosis?

    Cohort studySystemic sclerosis

  17. RMD Open

    Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study

    Cohort studySpondyloarthritis & PsA

  18. RMD Open

    Long-term sustainability of response to upadacitinib among patients with active rheumatoid arthritis refractory to biological treatments: results up to 5 years from SELECT-BEYOND

    Randomized controlled trialRA

  19. RMD Open

    Diagnosis challenges in inception cohorts in axial spondyloarthritis: the case of the French national DESIR cohort

    Cohort studySpondyloarthritis & PsA

  20. RMD Open

    Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis

    Cohort studyRA

  21. RMD Open

    No difference in clinical parameters and drug retention in PsA patients receiving b/tsDMARD monotherapy versus combination with methotrexate: data from the RABBIT-SpA registry

    Cohort studySpondyloarthritis & PsA

  22. RMD Open

    Impact of inflammation on cognitive function in patients with highly inflammatory rheumatoid arthritis

    Cross-sectional studyRA

  23. RMD Open

    What role do socioeconomic and clinical factors play in disease activity states in rheumatoid arthritis? Data from a large UK early inflammatory arthritis audit

    Cohort studyRA

  24. RMD Open

    Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children

    Cohort studyPediatric

  25. RMD Open

    Early clinical response associates with long-term outcomes with ixekizumab in radiographic axial spondyloarthritis

    Secondary analysisSpondyloarthritis & PsA

  26. RMD Open

    Twenty-year trajectories of morbidity in individuals with and without osteoarthritis

    Cohort studyOsteoarthritis

  27. RMD Open

    Large language model-driven sentiment analysis for facilitating fibromyalgia diagnosis

    Diagnostic or prognostic studyFibromyalgia & pain

  28. RMD Open

    Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: results from the phase 2a IRIS-RA study

    Randomized controlled trialRA

  29. RMD Open

    Sex-specific impact of inflammation on traditional cardiovascular risk factors and atherosclerosis in axial spondyloarthritis. A multicentre study of 913 patients

    Cohort studySpondyloarthritis & PsA

  30. RMD Open

    Anti-dsDNA IgE: a potential non-invasive test for prediction of lupus nephritis relapse

    Randomized controlled trialLupus & APS

  31. RMD Open

    Increased risk of cardiovascular events under the treatments with Janus kinase inhibitors versus biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a retrospective longitudinal population-based study using the Japanese health insurance database

    Cohort studyRA

  32. RMD Open

    Predictive utility of ANCA positivity and antigen specificity in the assessment of kidney disease in paediatric-onset small vessel vasculitis

    Cohort studyPediatric

  33. RMD Open

    Deep learning-based classification of erosion, synovitis and osteitis in hand MRI of patients with inflammatory arthritis

    Diagnostic or prognostic studyRA

  34. RMD Open

    Synthesis of guidance available for assessing methodological quality and grading of evidence from qualitative research to inform clinical recommendations: a systematic literature review

    Research articleAcross diseases

  35. RMD Open

    Rheumatoid arthritis and changes on spirometry by smoking status in two prospective longitudinal cohorts

    Cohort studyRA

  36. RMD Open

    Modifying T cell phenotypes using TYK2 inhibitor and its implications for the treatment of systemic lupus erythematosus

    Mechanistic studyLupus & APS

  37. RMD Open

    Factors Associated with Poor Mental Health in Patients with Axial Spondyloarthritis: Results from the International Map of Axial Spondyloarthritis (IMAS)

    Cross-sectional studySpondyloarthritis & PsA

  38. RMD Open

    CT informs detection and treatment options in rheumatoid arthritis complicated by pulmonary non-tuberculous mycobacterial disease from the FIRST registry

    Cohort studyRA

  39. RMD Open

    Anatomical pattern of entheseal and synovial fibroblast activation in patients with psoriasis and its risk of developing psoriatic arthritis

    Cohort studySpondyloarthritis & PsA

  40. RMD Open

    Two-year clinical follow-up enhances the diagnosis of early-stage hip osteoarthritis: data from check cohort

    Diagnostic or prognostic studyOsteoarthritis

All 899 Briefs in ExploreShowing Briefs 481–520 of 899, newest first